BDBM62551 MLS000035440::N-[4-Chloro-3-(4-hydroxymethyl-[1,2,3]triazol-1-yl)-5-oxo-2,5-dihydro-furan-2-yl]-benzamide::N-[4-chloranyl-3-[4-(hydroxymethyl)-1,2,3-triazol-1-yl]-5-oxidanylidene-2H-furan-2-yl]benzamide::N-[4-chloro-3-[4-(hydroxymethyl)-1-triazolyl]-5-oxo-2H-furan-2-yl]benzamide::N-[4-chloro-3-[4-(hydroxymethyl)triazol-1-yl]-5-oxo-2H-furan-2-yl]benzamide::N-[4-chloro-5-keto-3-(4-methyloltriazol-1-yl)-2H-furan-2-yl]benzamide::SMR000001125::cid_651191

SMILES CCOCn1nc2cc(N3CCCc4cc(C(=O)N5CCCCC5)cnc43)ccn2c1=O

InChI Key InChIKey=BFDLSHLXBHXSKG-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62551   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62551BDBM62551(US12577217, Example 1-57)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent